By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Live Trading NewsLive Trading NewsLive Trading News
  • Stocks
  • Forex
  • Gold
  • KNIGHTS
  • Luxury
  • Horse Racing
  • Trade Now
Search
Reading: Farmmi (FAMI) Gets an Upgrade
Share
Live Trading NewsLive Trading News
  • Stocks
  • Forex
  • Gold
  • KNIGHTS
  • Luxury
  • Horse Racing
  • Trade Now
Search
  • Stocks
  • Forex
  • Gold
  • KNIGHTS
  • Luxury
  • Horse Racing
  • Trade Now
Follow US
© 2024 LiveTradingNews.com - All Rights Reserved.
Live Trading News > Blog > Stocks > Asia > Farmmi (FAMI) Gets an Upgrade
2021

Farmmi (FAMI) Gets an Upgrade

John Heffernan
Last updated: February 12, 2021 11:39 am
John Heffernan
Share
3 Min Read
OTC, FAMI, Farmmi, Stock
OTC, FAMI, Farmmi, Stock
SHARE

Farmmi, Inc. (“Farmmi” or the “Company”) (NASDAQ: FAMI), an agriculture products supplier in China, today announced it received a new order from a long-term customer for dried mushrooms, which will be exported to Dubai.

Fami strategic objective is to build a global trading platform for agricultural products with Chinese geographical indications, with the help of modern artificial intelligence technology and in virtue of the operation mode of “Internet + Internet of Things + Factories + bases”, adding value to China’s high-quality agricultural products market.

As this takes shape we believe the value of the company will take off.

HEFFX Target Upgraded $4 in 2022 Buy Rating Issued

The shiitake mushroom market is forecasted to witness a CAGR of 9.11% during the forecast period (2020 – 2025).

  • Shiitake, which falls in the category of functional mushrooms, are being used in a wide variety of healthcare or pharmaceutical products thus, increasing there applicability beyond food and beverage. Therefore, there application as functional ingredient in medical industry is driving the market, as they are being increasingly incorporated as health supplements.
  • Currently, the bacterial and viral infections are rising around the globe, such as COVID19, therefore the shiitake mushroom application in the pharmaceutical sector is expected to increase further, as shiitake mushrooms are being used as medicine, for boosting the immune system, lowering blood cholesterol levels, hardening of the arteries, diabetes, eczema, colds and flu, treating prostate or breast cancer, and also act as as an anti-aging agent.
Image result for shitake mushrooms

Ms. Yefang Zhang, Farmmi’s Chairwoman and CEO, commented, “Farmmi’s diverse customer base is driving our continued expansion. 

We are benefiting from our leading position in the large domestic China market, growth in Japan and across Asia, North America, Europe, while developing opportunities in other markets worldwide. 

We made great strides in our business in 2020, which set in motion sales and marketing initiatives we are now benefiting from. 

We are excited about the increased adoption of healthy, nutrition-dense diets and more active lifestyles in our target markets. 

Our company’s excellent track record, brand awareness and broad product line is helping Farmmi become the fuel of choice for conscientious, health aware customers.”

Image result for Mu Err mushrooms

About Farmmi, Inc.

Headquartered in Lishui, Zhejiang, Farmmi, Inc. (NASDAQ: FAMI), is a leading agricultural products supplier, processor and retailer of Shiitake mushrooms, Mu Er mushrooms and other edible fungi.  For further information about the Company, please visit: http://ir.farmmi.com.cn/.

You Might Also Like

Bernardo Bellotto: A Master of Cityscapes

Knightsbridge: Redefining Global Markets with a Unified Vision

TotalEnergies to Drill in South Africa

Saudi Arabia’s Financial Sector

Knightsbridge: Pioneering a Comprehensive Digital Asset Ecosystem in 2025

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.

Subscribe our newsletter for latest news around the world. Let's stay updated!

By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Share This Article
Facebook Twitter Copy Link Print
Share
By John Heffernan
Follow:
John Heffernan is a BSc Economist with Honors. Currently working as an Analyst at KXCO, and has contributed on equities and Crypto at Live Trading News.
Previous Article Why Bitcoin $BTC will be Worth $1m
Next Article Today is Abraham Lincoln’s Birthday


Latest News

Revolutionizing Longevity and Quality of Life
Featured Fitness Headline News Health Lifestyle Lifestyles of the RIch and Famous Living Luxury Motivation Stem cells Thailand Thailand Travel May 19, 2025
Saudi Arabia’s Economic Surge
Blockchain for Government Crypto Digital Assets Gold Headline News KNIGHTS Knightsbridge Knightsbridge Insights KXCO KXCO Guide Must Read Ripple Shayne Heffernan USD XT May 19, 2025
Catholics and Muslims in Israel: A Call for Greater Political Voice
Catholic Headline News Opinion Politics Shayne Heffernan May 11, 2025
Qatar’s Venture Capital Surge
Featured Headline News Opinion Shayne Heffernan Shayne Heffernan Shayne Heffernan on Investments May 10, 2025

Stay Connected

235.3kFollowersLike
69.1kFollowersFollow
11.6kFollowersPin
56.4kFollowersFollow
4.4kFollowersFollow
//

Stay informed with LiveTradingNews.com – your ultimate destination for timely and insightful updates on global markets, finance, and investment trends. Explore the latest news and analysis to empower your trading decisions.

Quick Link

  • About us
  • Advertise
  • Send us a tip!
  • Privacy Policy
  • Contact us

Top Categories

  • Knightsbridge Insights
  • Featured
  • Stocks
  • Shayne Heffernan
  • Lifestyle

Sign Up for Our Newsletter

Subscribe to our newsletter to get our newest articles instantly!

Subscribe our newsletter for latest news around the world. Let's stay updated!

Live Trading NewsLive Trading News
Follow US
© 2025 LiveTradingNews - For The Traders, By The Traders – All Right Reserved By Knightsbridge Group
Welcome Back!

Sign in to your account

Register Lost your password?